机器学习预测特应性皮炎发作与疾病严重程度
基于丹麦皮肤队列878例特应性皮炎患者,采用分位数回归与提升随机森林分析2022年发作次数与2023年患者报告严重程度的关系。结果显示年发作次数与多数严重程度指标显著相关,发作严重程度、持续时间与次数是AD严重程度的重要预测因子,而疾病严重程度是年发作次数的最强预测因子之一。
要点
- 年发作次数越多,患者报告的生活质量越差,且可预测次年更严重的AD。
- 发作严重程度、持续时间和次数是AD严重程度的重要预测因子。
- 疾病严重程度是年发作次数最强的预测因子之一。
核心结论
- 较高的发作次数与较低的生活质量相关,并可作为次年更严重AD的预测因子。
- 结果提示发作评估对严重程度判断或疾病预后具有意义,并建议在治疗决策中设定可接受发作次数的阈值。
研究设计与样本
- 使用丹麦皮肤队列(Danish Skin Cohort)中来自丹麦的大样本AD患者数据。
- 采用分位数回归模型分析2022年报告发作次数与2023年患者报告严重程度指标间的关联。
主要发现
- 共纳入878例AD患者,年龄中位数(IQR)为49.0(39.0-59.0)岁。
- 2022年报告0次年发作者26例,1至5次者405例,6至10次者169例,超过10次者278例。
- 分位数回归显示2022年报告的年发作次数与2023年多数患者报告严重程度指标显著相关。
- 调整基线PO-SCORAD评分后,2022年年发作次数仍与POEM和DLQI显著相关。
- 机器学习模型中,发作严重程度、持续时间和次数是AD严重程度最重要的预测因子之一,疾病严重程度是年发作次数最强的预测因子之一。
临床怎么用
- 在AD严重程度评估与预后判断中应纳入发作次数与发作特征。
- 治疗决策可考虑设定可接受的年发作次数阈值,以改善疾病控制与生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The disease course of atopic dermatitis (AD) is characterized by fluctuations and frequent flares, contributing to the disease burden and impairment in life quality. However, flares are not necessarily considered in severity classifications and clinical treatment decisions. OBJECTIVE: To validate the predictability of flares and disease severity in patients with AD and quantify the importance of predictors. DESIGN, SETTING, AND PARTICIPANTS: Using the Danish Skin Cohort, a large population of patients with AD from Denmark with data on disease severity and flare patterns, quantile regression models were conducted to investigate the association between the number of flares reported in 2022 and patient-reported severity measures reported in 2023. Additionally, boosted random forests were used to explore predictors of both annual flares and disease severity. Analyses were conducted from January to December of 2024. MAIN OUTCOMES AND MEASURES: Severity of AD as well as frequency, duration, and severity of flares were the main variables under consideration. RESULTS: This study included 878 patients with AD (median [IQR] age, 49.0 [39.0-59.0] years), with 26 reporting 0 yearly flares, 405 reporting 1 to 5 yearly flares, 169 reporting 6 to 10 yearly flares, and 278 patients reporting more than 10 yearly flares in 2022. From the quantile regression, the number of annual flares reported in 2022 was significantly associated with most patient-reported severity measures reported in 2023. When adjusting for the Patient-Oriented Scoring of Atopic Dermatitis score at baseline, the number of annual flares reported in 2022 was significantly associated with the Patient-Oriented Eczema Measure and Dermatology Life Quality Index. Using predictive machine learning models, flare severity, duration, and number were among the most important predictors of AD severity, while disease severity was among the strongest predictors of the number of annual flares. CONCLUSIONS AND RELEVANCE: This cohort study found that a higher number of flares was associated with lower quality of life and was identified as a predictor of more severe AD in the following year. These results highlight the relevance of flares in the assessment of severity or disease prognosis and suggest the need for a threshold for an acceptable number of flares in treatment decisions to achieve better disease control and improved quality of life for patients.
引用
- Nielsen ML, Nymand LK, Pena AD, et al. Predictors of Flares and Disease Severity in Patients With Atopic Dermatitis Using Machine Learning. JAMA Dermatol. 2025. PMID: 40668566. doi:10.1001/jamadermatol.2025.2073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。